Waters and DAISO Sign Marketing Agreement for Bulk Process Chromatography Media
February 17 2010 - 9:00AM
PR Newswire (US)
Waters to Make DAISO Media Available to Pharmaceutical and
Biopharmaceutical Purification Customers MILFORD, Mass. and OSAKA,
Japan, Feb. 17 /PRNewswire/ -- Waters Corporation and DAISO CO.,
LTD. jointly announced today that they are entering into a
collaborative agreement to globally market and supply DAISOGEL(TM)
bulk packing materials for process chromatography. The combined
purification expertise of both organizations will aid
pharmaceutical and biopharmaceutical companies as they move from
lab-scale purifications into pilot plant and process-scale
manufacturing. To simplify scaling-up purification methods,
DAISOGEL(TM) columns are packed using Waters patented Optimum Bed
Density (OBD(TM)) Technology(1). OBD Technology enables analytical
column performance and industry best lifetime in larger preparative
columns. Scientists will save time by eliminating the need for
subsequent method redevelopment as they increase in scale. As drug
manufacturers invest significant amounts of money to manufacture
new drug substances, they need solid commitments from established
high quality process bulk suppliers with a long track record for
synthesizing chromatographic media for drug purification processes.
DAISO's comprehensive quality control system is based on ISO 9001
and has met the quality requirements of global pharmaceutical
companies. DAISO also has a DMF (Drug Master File) on file with the
U.S. Food and Drug Administration (FDA) for the DAISOGEL(TM)
packing materials. Whether they need gram quantity amounts or
hundreds of kilograms of bulk media, contract manufacturing
organizations, innovator pharmaceutical, biopharmaceutical, natural
product, and generic pharmaceutical laboratories can find the media
they need in the right quantity and quality from Waters
Corporation. DAISOGEL(TM) packing materials and packed HPLC columns
are available from Waters. For more information:
http://www.waters.com/purification About DAISO (
http://www.daiso-co.com/eng ) DAISO provides a various range of
products and technical services to such industries as
pharmaceuticals, agrochemicals, electronics, machinery, textile and
construction as a technology-oriented chemical company of Japan.
Providing high technology and high performance materials, DAISO
contributes to global environmental conservation, industrial
development and the improvement of living comfort and safety. With
revenue of 76.7 billion Japanese yen and 745 employees for the
fiscal year ended March 31, 2009, DAISO is supplying a variety of
high-quality products for global customers. About Waters
Corporation ( http://www.waters.com/ ) Waters Corporation creates
business advantages for laboratory-dependent organizations by
delivering practical and sustainable innovation to enable
significant advancements in such areas as healthcare delivery,
environmental management, food safety and water quality worldwide.
Pioneering a connected portfolio of separations science, laboratory
information management, mass spectrometry and thermal analysis,
Waters technology breakthroughs and laboratory solutions provide an
enduring platform for customer success. With revenue of $1.5
billion in 2009 and 5,200 employees, Waters is driving scientific
discovery and operational excellence for customers worldwide.
Waters, The Science of What's Possible and OBD are trademarks of
Waters Corporation. DAISOGEL is a trademark of DAISO CO., LTD. (1)
US Patent Number 7,399,410 and UK Patent Number GB 2408 469
DATASOURCE: Waters Corporation CONTACT: Brian J. Murphy, Public
Relations Manager of Waters Corporation, +1-508-482-2614, Web Site:
http://www.waters.com/
Copyright